Premarket Decliner
RAPP Rapport Therapeutics27.54+2.21+8.7%
Premarket:20.78-6.76 (-24.6%)
Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement
Globe NewswireWed, 28-Oct 6:00 AM
RAPP Rapport Therapeutics28.70+0.10 (+0.4%)
RAPP Rapport Therapeutics27.31-2.26 (-7.6%)
RAPP Rapport Therapeutics32.49-1.64 (-4.8%)
RAPP Rapport Therapeutics22.59-5.44 (-19.4%)
RAPP Rapport Therapeutics27.89-3.58 (-11.4%)